Assignee
C4X DISCOVERY LTD
GB·6 granted patents·6 pending applications·27 citations·filing 2015–2024
Top patents by PatentIndex Score
12 records- 0192US11753398B2Therapeutic compoundsC4X DISCOVERY LTD·Filed 2021·Granted Sep 12, 2023·2 cites·3 claims
- 0292US11130746B2Therapeutic compoundsC4X DISCOVERY LTD·Filed 2020·Granted Sep 28, 2021·3 cites·7 claims
- 0391US10696654B2Therapeutic compoundsC4X DISCOVERY LTD·Filed 2017·Granted Jun 30, 2020·10 cites·7 claims
- 0490US10611760B2Therapeutic compounds as inhibitors of the orexin-1 receptorC4X DISCOVERY LTD·Filed 2015·Granted Apr 7, 2020·9 cites·5 claims
- 0578US12024509B2Therapeutic compounds as inhibitors of the orexin-1 receptorC4X DISCOVERY LTD·Filed 2020·Granted Jul 2, 2024·1 cites·23 claims
- 0672US12098148B2Therapeutic compoundsC4X DISCOVERY LTD·Filed 2019·Granted Sep 24, 2024·2 cites·32 claims
- 0765US2025084075A1Therapeutic compoundsC4X DISCOVERY LTD·Filed 2024·Application pending·0 cites
- 0862US2024424112A1Tetrahydroisoquinoline compounds that are keap1 binders.C4X DISCOVERY LTD·Filed 2022·Application pending·0 cites
- 0958US2025136577A1Heterocyclic derivatives as malt1 inhibitorsC4X DISCOVERY LTD·Filed 2023·Application pending·0 cites
- 1051US2023159511A1Tetrahydroisoquinoline compounds as nrf2 activatorsC4X DISCOVERY LTD·Filed 2021·Application pending·0 cites
- 1150US2023167084A1Tetrahydroisoquinoline compounds as nrf2 activatorsC4X DISCOVERY LTD·Filed 2021·Application pending·0 cites
- 1244US2018096112A1Method for determining three-dimensional structures of dynamic moleculesC4X DISCOVERY LTD·Filed 2017·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →